No good direct clinical evidence shows that melatonin causes or treats histamine intolerance. Most of the research linking melatonin to mast cells is preclinical or mechanistic, not conducted in people with suspected histamine intolerance.
Feeling worse after taking melatonin doesn’t by itself prove a histamine reaction — general side effects, dose and timing, product variability, co-ingredients, or medication interactions could explain it instead. Severe allergic-type symptoms, such as breathing difficulty or swelling, need prompt medical evaluation rather than a self-applied histamine explanation.
What we actually know about melatonin and histamine intolerance
Evidence in this area falls into different tiers, and they shouldn’t be treated as equivalent.
Direct clinical studies on melatonin and histamine intolerance are lacking. Suspected histamine intolerance also doesn’t have a single confirmatory lab test, which makes evaluating any proposed trigger or treatment harder to pin down.
Mast-cell and circadian research linking melatonin to histamine biology is mostly preclinical or mechanistic, not human HIT trials. General melatonin safety, by contrast, has been studied directly in humans, as has how gummy product content compares to the label.
Many readers reach this page while researching nighttime symptoms — covered separately in our guides on histamine intolerance and insomnia and histamine dump at night. Those explain the symptom patterns; this page focuses on the melatonin evidence itself.
Does melatonin raise histamine or cause histamine intolerance?
Current evidence doesn’t establish that oral melatonin causes histamine intolerance or raises histamine in a way that produces a clinical HIT syndrome.
That’s not the same as proving it’s impossible — the direct research simply hasn’t been done. There’s also no clinical evidence that melatonin reliably lowers histamine in people with suspected HIT.
What mast-cell research can — and cannot — tell us
Preclinical and cell-based research suggests melatonin can influence mast-cell activation and inflammatory signaling — but this line of evidence has real limits.
A 2013 study by Maldonado et al. tested melatonin’s effect on the RBL-2H3 cell line, a rat mast-cell/basophil-like model, not human tissue or patients. A 2021 review in the Journal of Pineal Research covers mechanistic and circadian links between mast cells, melatonin, and inflammatory mediators.
A 2024 paper in Annals of Allergy, Asthma & Immunology discusses melatonin’s potential as a therapeutic agent by inhibiting mast-cell activation, but it isn’t a clinical trial in people with histamine intolerance or MCAS.
None of this evidence establishes oral melatonin as a clinically proven mast-cell stabilizer for HIT or MCAS. An MCAS diagnosis alone also doesn’t predict whether melatonin will help or worsen someone’s symptoms.
Why someone might feel worse after taking melatonin
A reaction after taking melatonin can have several possible explanations, and current evidence does not establish a histamine-specific mechanism.
Consider:
- A known melatonin side effect, such as headache or daytime grogginess
- The dose taken or its timing relative to sleep
- Variability between actual product content and the label
- Other ingredients taken in the same product or alongside it
- An interaction with another medication
- An unrelated sleep or medical issue
- A hypersensitivity or allergic-type reaction to the product
These possibilities should be considered before assuming a histamine-specific mechanism. Several are not specific to dietary histamine.
What the 0.3 mg melatonin study actually showed
A frequently cited study is Zhdanova et al. 2001, which studied adults over 50, including participants with reduced sleep efficiency and normal sleepers.
The study compared 0.1 mg, 0.3 mg, and 3.0 mg doses. The 0.3 mg dose raised plasma melatonin into the normal nighttime range and improved sleep efficiency in the insomnia group. The 3.0 mg dose also improved sleep, but plasma melatonin stayed elevated into daylight hours and was linked to hypothermia in that study.
This study does not show that the body naturally produces 0.3 mg of melatonin at night. It does not establish 0.3 mg as a universal dose for histamine intolerance or MCAS. And it does not prove that lower doses are better tolerated specifically in histamine-sensitive people — that comparison wasn’t tested.
Can melatonin cause flushing or itching?
Flushing has been reported, including in a 2025 case report. Skin irritation has also appeared among rare reported adverse events, but this evidence does not establish a histamine-specific mechanism or a characteristic itching syndrome.
One 2025 case report described a woman taking 2 mg of melatonin who developed flushing that resolved after she stopped the supplement; the same case also involved changes in growth hormone and IGF-1.
A single case report can’t establish a histamine-intolerance mechanism — it shows an association in one person, not a proven cause. Flushing itself has many possible causes, and this evidence doesn’t support treating it as a histamine-specific sign.
Melatonin gummies and label accuracy
A 2023 study by Cohen et al. tested 25 melatonin gummy products sold in the US.
Twenty-two of the 25 products were inaccurately labeled. Among products that did contain melatonin, actual content ranged from 74% to 347% of the labeled amount.
This means the dose someone actually takes may differ substantially from what’s printed on the label — which matters when comparing personal experiences across products. It doesn’t mean gummy ingredients like dyes or citric acid trigger histamine reactions, that all gummies are problematic for histamine intolerance, or that third-party testing guarantees an exact, consistent dose.
General melatonin safety
Short-term melatonin use appears relatively safe for most people, according to the NIH’s National Center for Complementary and Integrative Health.
Commonly reported trial adverse effects include daytime sleepiness, headache, and dizziness. Long-term safety data remain limited, and safety evidence in pregnancy and breastfeeding is also limited.
Melatonin can interact with certain medications, so this matters for anyone taking prescription drugs regularly. Allergic reactions are also possible. People who are pregnant, breastfeeding, taking other medications, or managing a chronic condition should get personalized guidance from a clinician rather than relying on a general dose recommendation.
What to do if melatonin seems to make you feel worse
If melatonin seems to make you feel worse, a few steps can help you figure out why:
- Don’t assume the reaction proves histamine intolerance or MCAS activation
- Review the actual dose and formulation, plus anything else taken at the same time
- Check medication interactions with a clinician or pharmacist
- Discuss recurrent or persistent reactions with a clinician before retrying or changing the dose
- Seek urgent medical care for severe allergic or anaphylaxis-type symptoms
References
This article draws on human trial data, case reports, mechanistic/preclinical research on melatonin and mast cells, and general safety guidance from the NIH.
- Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727-4730. doi:10.1210/jcem.86.10.7901
- Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA. 2023;329(16):1401-1402. doi:10.1001/jama.2023.2296
- Pham L, Baiocchi L, Kennedy L, et al. The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators. J Pineal Res. 2021;70(2):e12699. doi:10.1111/jpi.12699
- Maldonado MD, Garcia-Moreno H, Calvo JR. Melatonin protects mast cells against cytotoxicity mediated by chemical stimuli PMACI: possible clinical use. J Neuroimmunol. 2013;262(1-2):62-65. doi:10.1016/j.jneuroim.2013.06.013
- Ye H, Cheng P, Jin B, Xu H, Wang B. Melatonin inhibits mast cell activation, indicating its potential as a therapeutic agent in inflammatory diseases. Ann Allergy Asthma Immunol. 2024;132(5):659-661. doi:10.1016/j.anai.2024.01.005
- Besag FMC, Vasey MJ, Lao KSJ, Wong ICK. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review. CNS Drugs. 2019;33(12):1167-1186. doi:10.1007/s40263-019-00680-w
- Menczel Schrire Z, Phillips CL, Chapman JL, et al. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis. J Pineal Res. 2022;72(2):e12782. doi:10.1111/jpi.12782
- Di Vincenzo A, Zabeo E, Purificati C, Rossato M. Growth Hormone Increase Induced by Oral Administration of Melatonin in a Young Woman With Sleep Disturbances. JCEM Case Rep. 2025;3(2):luaf006. doi:10.1210/jcemcr/luaf006
- Reese I, Ballmer-Weber B, Beyer K, et al. Guideline on management of suspected adverse reactions to ingested histamine. Allergol Select. 2021;5:305-314. doi:10.5414/ALX02269E
- National Center for Complementary and Integrative Health. Melatonin: What You Need To Know. Bethesda (MD): National Institutes of Health.
